EQUIFAX INC·4

Nov 17, 4:06 PM ET

Ploder Rodolfo O 4

4 · EQUIFAX INC · Filed Nov 17, 2023

Insider Transaction Report

Form 4
Period: 2023-11-15
Ploder Rodolfo O
Pres-Equifax Intl
Transactions
  • Exercise/Conversion

    Common Stock

    2023-11-15$127.37/sh+12,233$1,558,11798,262 total
  • Sale

    Common Stock

    2023-11-15$198.54/sh4,207$835,26193,561 total
  • Exercise/Conversion

    Stock Option/Right to Buy

    2023-11-1512,2330 total
    Exercise: $127.37From: 2022-02-22Exp: 2025-02-22Common Stock (12,233 underlying)
  • Sale

    Common Stock

    2023-11-15$201.15/sh3,215$646,69380,029 total
  • Sale

    Common Stock

    2023-11-15$195.01/sh199$38,80798,006 total
  • Sale

    Common Stock

    2023-11-15$200.55/sh2,849$571,38083,244 total
  • Sale

    Common Stock

    2023-11-15$196.66/sh295$58,01597,768 total
  • Sale

    Common Stock

    2023-11-15$199.17/sh7,468$1,487,38886,093 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    445
Footnotes (8)
  • [F1]The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/15/2023.
  • [F2]Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
  • [F3]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $195.01 to $195.02, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
  • [F4]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $196.38 to $196.69, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
  • [F5]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $197.82 to $198.81, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
  • [F6]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $198.82 to $199.79, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
  • [F7]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $199.84 to $200.815, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
  • [F8]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $200.84 to $201.58, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES